BioSpace News Archive

WHO and Merck must do more to ensure vaccines are available and that healthcare workers are protected throughout the Congo, where the second worst Ebola outbreak in history has killed almost 300 people and has reached a major population center.

Eli Lilly and Company (NYSE: LLY) and Evidation Health, a health and measurement company that helps innovative life sciences and health care companies understand how everyday behavior and health interact, announced today that they have expanded their collaboration with a multi-year agreement to provide Lilly with global access to Evidation’s Andromeda data platform.

MYOS RENS Technology Inc. issued the following letter to shareholders from MYOS CEO Joseph Mannello

Glenmark Pharmaceuticals, a global innovative pharmaceutical company, today announced the presentation of new pharmacokinetic data from the ongoing Phase 1 trial of GBR 1302, a HER2xCD3 bispecific antibody, at the European Society for Medical Oncology Immuno-Oncology (ESMO-IO) Congress 2018 in Geneva, Switzerland

Survey Conducted by Culture Data Website Comparably Ranks Large, Midsize and Small US Companies in Areas Including Compensation and Leadership

Twenty years after reaching a landmark legal settlement with the tobacco companies, the states continue to spend only a small fraction of their billions in tobacco revenue on programs to prevent kids from using tobacco and help smokers quit, according to a report released today by a coalition of public health organizations.

Tilray, Inc. (NASDAQ:TLRY), a global pioneer in cannabis production and distribution, today announced an investment in Québec-based cannabis producer, ROSE LifeScience Inc. (“ROSE”) and an exclusive sale, supply, distribution and marketing agreement between High Park Farms Ltd. (“High Park”), a wholly-owned subsidiary of Tilray, and ROSE.

Pfizer Inc. (NYSE:PFE) announced today the initiation of a Phase 3 program for its 20-Valent pneumococcal conjugate vaccine (20vPnC) candidate, PF-06482077, for the prevention of invasive disease and pneumonia caused by Streptococcus pneumoniae serotypes in the vaccine in adults aged 18 years and older.

Green Relief Inc., Canada’s leading licensed producer of medical cannabis using aquaponics as a growing method, today announced it has entered a share purchase agreement for a majority stake of Bodhi Research & Development Inc. (“Bodhi Research”).

Grünenthal expands its portfolio with an innovative technology for individualised dosing